Acorah Software Products - Accounts Production19.2.450truetruefalsetrueNo description of principal activity1 June 202531 May 202631 May 202616452222Mr Aws Al-GhabanMr Nibal Al-Ghabbaniso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure164522222025-05-31164522222026-05-31164522222025-06-012026-05-3116452222frs-bus:PrivateLimitedCompanyLtd2025-06-012026-05-3116452222frs-bus:FilletedAccounts2025-06-012026-05-3116452222frs-bus:Micro-entities2025-06-012026-05-3116452222frs-bus:EntityHasNeverTraded2025-06-012026-05-3116452222frs-bus:AuditExempt-NoAccountantsReport2025-06-012026-05-3116452222frs-bus:Director12025-06-012026-05-3116452222frs-bus:Director22025-06-012026-05-31
Registered number: 16452222
Britwell Pharma Ltd
Unaudited Dormant Financial Statements
For The Year Ended 31 May 2026
Britwell Pharma Ltd
Balance Sheet
As At 31 May 2026
Balance Sheet
Registered number: 16452222
2026
£
Current assets
1,000
NET CURRENT ASSETS
1,000
TOTAL ASSETS LESS CURRENT LIABILITIES
1,000
NET ASSETS
1,000
CAPITAL AND RESERVES
1,000
Notes
1.General Information
Britwell Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16452222. The registered office is 479 Chester Road, Manchester, M16 9HF.
2.Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 31 May 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.